Form Type and Filing Date: This is an 8-K Current Report filed by LabCorp Holdings Inc. on July 30, 2026, reporting events as of that same date. Item 2.02 - Results of Operations and Financial Condition: The filing indicates disclosure of results of operations and financial condition information, though the specific financial details are not fully visible in the provided document excerpt. Item…

Our analysis rates this filing BULLISH. LabCorp demonstrates exceptionally strong financial performance with multiple positive signals across earnings, guidance, and capital allocation. The company delivered a significant earnings beat with diluted EPS up 28.5% YoY and adjusted EPS up 14.9% YoY on…

Concern level: LOW (1.8/10).

Notable risk changes: Strong Q2 2026 financial performance: Revenue $3.73B (+5.8% YoY), Diluted EPS $3.64 (+28.5% YoY), Adjusted EPS $4.99 (+14.9% YoY); Raised full-year 2026 guidance: Revenue growth 5.4-6.3% (up 30bps at midpoint), Adjusted EPS $18.10-$18.55 (up 30 cents at midpoint); Expanded capital return program: $1.0B increase in share repurchase authorization (total remaining $1.4B), paid $353.8M in Q2…

The model predicts LH will underperform the S&P 500 by about 0.1% over 30 days. This is model analysis for research, not investment advice.